NWBO has been allowed to produce the vaccine under UK specials for years. Efficacy was not known as trial was still continuing, safety record may have allowed initial approval for Specials. How can they determine efficacy without TLD published or submitted?
Meirluc there is a lot of talking between Les and bigger financiers. That’s a fact. Much what he (Les) said then later turned out not come to pass. ( much to the annoying of those that receive that info from him)
IMO Les loves to talk when the company needs finances… IMO